# Spyre Therapeutics, Inc.: Form 8-K, filed Mar 6, 2025

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: 8-K
- Filed: 2025-03-06
- Accepted by EDGAR: Mar 6, 2025, 21:15 ET
- Period: 2025-02-28
- Accession: 0001193125-25-048423
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000119312525048423/d861533d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000119312525048423/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000119312525048423/d861533d8k.htm

Filed Mar 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-048423. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.